EUROPE VETERINARY VACCINES MARKET 2022-2028

Lifesciences | Pharmaceuticals

EUROPE VETERINARY VACCINES MARKET 2022-2028

Market by Animal Type, Disease Type, Product Type, and Country Outlook | Forecast 2022-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

A study by Triton Market Research on Europe’s veterinary vaccines market shows that it would develop with a CAGR of 7.06% in the forecast period 2022-2028.


Report scope can be customized per your requirements. Request For Customization

The countries studied in this market include:

•         Germany

•         Spain

•         France

•         Italy

•         The United Kingdom

•         Rest of Europe

Europe is home to a number of globally renowned veterinary pharmaceutical companies. The presence of such top market players attracts a large amount of foreign investment into the region, which drives the overall market here. Further, notable advancements in technology, research & development, advanced vaccines, innovation, etc., are some of the key factors that enable and drive the growth of the veterinary vaccines market in the European region.

While immunizations are recommended for the overall health of pet animals in Spain, the only vaccine mandated in the country is the rabies vaccine. The government authorizes rabies vaccination for dogs, cats, and ferrets every 3 years. Moreover, vaccines for distemper, parvovirus, and other diseases are also provided to dogs across Spain. Thus, the regulations & initiatives by the government largely contribute to the growth of the veterinary vaccines market in the country. 

There are nearly 2 million pet dogs and 3 million pet cats in the Netherlands. In addition, the nation boasts of having one of the biggest livestock sectors in the European region, with more than 100 million cattle, pigs, and hens. It also accounts for the largest meat exports in the region. With such a vast animal population, vaccination is among the most effective techniques to tackle animal diseases and promote their health & welfare. 

Canine diseases are the type of diseases that affect dogs and other related species. Some of the most common canine diseases are rabies, canine distemper, giardia, parainfluenza, Lyme disease, and so on. Dogs are owned, adopted, or domesticated widely. The vast dog population makes a large number of them prone to these diseases. Thus, the market by canine disease type is an excellent opportunity for manufacturers of veterinary vaccines.

The studied report assesses the market’s growth based on animal type, disease type, and product type. Here, the disease type segment comprises canine disease, bovine disease, porcine disease, aquaculture disease, poultry disease, and other disease types.

Leading companies considered in the veterinary vaccines market include Virbac SA, Elanco Animal Health Inc, Vaxxinova GmbH, Hipra, Boehringer Ingelheim International GmbH, and Zoetis Inc.

Boehringer Ingelheim is a healthcare company focusing on improving the health and quality of life of humans as well as animals. Its portfolio features over 200 products for cats, dogs, pigs, horses, poultry, and cattle, and has over 20 R&D facilities in Europe and other parts of the world. The company’s product, VAXXITEK® HVT+IBD+ILT, is the first vaccine to offer protection in one shot from Marek’s Disease, Infectious Bursal Disease Infectious, and Laryngotracheitis. Boehringer Ingelheim was founded in 1855 and is headquartered in Ingelheim am Rhein, Germany.

 

Key deliverables of the report: 

       Market CAGR during the forecasting years 2022-2028

       Detailed data highlighting key insights, industry components, and market strategies

     Comprehensive information and estimation of the veterinary vaccines market revenue growth in Europe and its influence on the parent market 

       In-depth study of forthcoming trends in consumer behavioral patterns 

       A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

     A wide-ranging study of factors that will challenge the Europe veterinary vaccines market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE VETERINARY VACCINES MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE VETERINARY VACCINES MARKET

2.2. KEY INSIGHTS

2.2.1. INCREASING INNOVATION BY MARKET PARTICIPANTS

2.2.2. ADVANCEMENTS IN VACCINE AND DIAGNOSTIC TECHNOLOGY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VALUE CHAIN ANALYSIS

2.6. KEY BUYING CRITERIA

2.7. REGULATORY FRAMEWORK

2.8. VENDOR SCORECARD

2.9. KEY MARKET STRATEGIES

2.9.1. MERGERS & ACQUISITIONS

2.9.2. CONTRACTS & AGREEMENTS

2.9.3. PRODUCT LAUNCHES

2.9.4. EXPANSIONS & DIVESTITURES

2.10. MARKET DRIVERS

2.10.1. HIGH VACCINE DEMAND DUE TO INCREASING ANIMAL POPULATION AND DISEASES

2.10.2. GOVERNMENT-ORGANIZED VACCINATION DRIVES      

2.10.3. ADVANCED VACCINE RESEARCH AND DEVELOPMENT

2.11. MARKET CHALLENGES

2.11.1. LACK OF AWARENESS AND SCARCITY OF SKILLED VETERINARIANS

2.11.2. STRINGENT RULES AND REGULATIONS PERTAINING TO VACCINE USE

2.12. MARKET OPPORTUNITIES

2.12.1. GROWING USE OF VACCINES IN THE EUROPEAN MARKET

2.12.2. RISING DEMAND FOR COMPANION ANIMALS

3. EUROPE VETERINARY VACCINES MARKET OUTLOOK – BY ANIMAL TYPE

3.1. LIVESTOCK ANIMALS

3.1.1. CATTLE

3.1.2. PIGS

3.1.3. POULTRY

3.1.4. SHEEP

3.1.5. OTHER LIVESTOCK ANIMALS

3.2. COMPANION ANIMALS

3.2.1. CANINE

3.2.2. FELINE

3.2.3. EQUINE

3.3. AQUACULTURE

4. EUROPE VETERINARY VACCINES MARKET OUTLOOK – BY DISEASE TYPE

4.1. CANINE DISEASE

4.2. PORCINE DISEASE

4.3. BOVINE DISEASE

4.4. POULTRY DISEASE

4.5. AQUACULTURE DISEASE

4.6. OTHER DISEASE TYPES

5. EUROPE VETERINARY VACCINES MARKET OUTLOOK – BY PRODUCT TYPE

5.1. ATTENUATED VACCINES

5.2. INACTIVATED VACCINES

5.3. TOXOID VACCINES

5.4. CONJUGATE VACCINES

5.5. DNA VACCINES

5.6. RECOMBINANT VACCINES

5.7. SUBUNIT VACCINES

6. EUROPE VETERINARY VACCINES MARKET – COUNTRY OUTLOOK

6.1. UNITED KINGDOM

6.2. GERMANY

6.3. FRANCE

6.4. SPAIN

6.5. ITALY

6.6. REST OF EUROPE

7. COMPETITIVE LANDSCAPE

7.1. BOEHRINGER INGELHEIM INTERNATIONAL GMBH

7.2. BRILLIANT BIO PHARMA

7.3. CEVA SANTE ANIMALE

7.4. ELANCO ANIMAL HEALTH INC

7.5. HESTER BIOSCIENCES LTD

7.6. HIPRA

7.7. INDIAN IMMUNOLOGICALS LIMITED

7.8. MERCK ANIMAL HEALTH

7.9. PHIBRO ANIMAL HEALTH

7.10. VAXXINOVA GMBH

7.11. VIRBAC SA

7.12. ZOETIS INC

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: EUROPE VETERINARY VACCINES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: VENDOR SCORECARD

TABLE 4: EUROPE VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)

TABLE 5: EUROPE VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 6: EUROPE VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)

TABLE 7: EUROPE VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)

TABLE 8: EUROPE VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 9: EUROPE VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: VALUE CHAIN ANALYSIS

FIGURE 3: KEY BUYING CRITERIA

FIGURE 4: EUROPE VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2021 & 2028 (IN %)

FIGURE 5: EUROPE VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

FIGURE 6: EUROPE VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2021 & 2028 (IN %)

FIGURE 7: EUROPE VETERINARY VACCINES MARKET, BY CATTLE, 2022-2028 (IN $ MILLION)

FIGURE 8: EUROPE VETERINARY VACCINES MARKET, BY PIGS, 2022-2028 (IN $ MILLION)

FIGURE 9: EUROPE VETERINARY VACCINES MARKET, BY POULTRY, 2022-2028 (IN $ MILLION)

FIGURE 10: EUROPE VETERINARY VACCINES MARKET, BY SHEEP, 2022-2028 (IN $ MILLION)

FIGURE 11: EUROPE VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)

FIGURE 12: EUROPE VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)

FIGURE 13: EUROPE VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2021 & 2028 (IN %)

FIGURE 14: EUROPE VETERINARY VACCINES MARKET, BY CANINE, 2022-2028 (IN $ MILLION)

FIGURE 15: EUROPE VETERINARY VACCINES MARKET, BY FELINE, 2022-2028 (IN $ MILLION)

FIGURE 16: EUROPE VETERINARY VACCINES MARKET, BY EQUINE, 2022-2028 (IN $ MILLION)

FIGURE 17: EUROPE VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2028 (IN $ MILLION)

FIGURE 18: EUROPE VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2021 & 2028 (IN %)

FIGURE 19: EUROPE VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 20: EUROPE VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 21: EUROPE VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 22: EUROPE VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 23: EUROPE VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2028 (IN $ MILLION)

FIGURE 24: EUROPE VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2022-2028 (IN $ MILLION)

FIGURE 25: EUROPE VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 26: EUROPE VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 27: EUROPE VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 28: EUROPE VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 29: EUROPE VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 30: EUROPE VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 31: EUROPE VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 32: EUROPE VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2028 (IN $ MILLION)

FIGURE 33: EUROPE VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 34: UNITED KINGDOM VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 35: GERMANY VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 36: FRANCE VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 37: SPAIN VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 38: ITALY VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

FIGURE 39: REST OF EUROPE VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;